Patents Assigned to Quantum Materials Corporation
  • Diagnostic test for vaccine validation and authentication and methods of use thereof
    Patent number: 11209428
    Abstract: The present invention encompasses a diagnostic test and method to authenticate the veracity of a vaccine. The diagnostic test and method are especially useful in a specific and sensitive immunochromatographic assay, performable within about 15 minutes for the authentication, validation, and veracity of a vaccine, such as a COVID-19 vaccine, in a vial prior to administration to a human.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: December 28, 2021
    Assignee: Quantum Materials Corporation
    Inventors: Andrew Robinson, Krishna Kowlgi, Stephen Squires, Brent Wade Ferguson, Nathanael J. Barree
  • Continuous synthesis of high quantum yield InP/ZnS nanocrystals
    Patent number: 9577149
    Abstract: The invention relates to a continuous-flow synthesis process for the preparation of high quality indium phosphide/zinc sulfide core/shell semiconduting nanocrystals in particular quantum dots (QD) conducted in a micro-reaction system comprising at least one mixing chamber connected to one reaction chamber.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: February 21, 2017
    Assignee: Quantum Materials Corporation
    Inventors: Huachang Lu, Werner Hoheisel, Leslaw Mleczko, Stephan Nowak